ID   JAM-ICR
AC   CVCL_A9QB
DR   Wikidata; Q102114291
RX   PubMed=33165868;
CC   Population: Iranian.
CC   Doubling time: 23.9 hours (PubMed=33165868).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=33165868
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13,16.2
ST   D21S11: 27,33.2
ST   D2S1338: 20,24
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10
ST   FGA: 22,24
ST   SE33: 16,20
ST   TH01: 6,7
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
RX   PubMed=33165868; DOI=10.1007/s13577-020-00456-1;
RA   Zareinejad M., Faghih Z., Ariafar A., Safaei A., Ghaderi A.;
RT   "Establishment of a bladder cancer cell line expressing both
RT   mesenchymal and epithelial lineage-associated markers.";
RL   Hum. Cell 34:675-687(2021).
//